Quantum Genomics Société Anonyme (QNNTF)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.71 Million EUR | 59.95% |
| 2022 | 1.18 Million EUR | -64.11% |
| 2021 | 3.3 Million USD | 40.14% |
| 2020 | 2.35 Million USD | -80.46% |
| 2019 | 12.06 Million USD | -22.28% |
| 2018 | 15.52 Million USD | 25.92% |
| 2017 | 12.32 Million USD | 399.05% |
| 2016 | 2.47 Million USD | 39.93% |
| 2015 | 1.76 Million USD | 3283.27% |
| 2014 | 52.17 Thousand USD | -38.06% |
| 2013 | 84.23 Thousand USD | -88.07% |
| 2012 | 705.91 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.2 Million USD | 0.0% |
| 2023 FY | 151.42 Thousand USD | -87.23% |
| 2023 Q3 | 355.42 Thousand USD | 409.84% |
| 2023 Q4 | 334.69 Thousand USD | -5.83% |
| 2023 Q2 | 69.71 Thousand USD | -88.23% |
| 2023 Q1 | 592.41 Thousand USD | -22.75% |
| 2022 FY | 1.18 Million EUR | -64.11% |
| 2022 Q4 | 766.91 Thousand USD | 9.27% |
| 2022 Q3 | 701.83 Thousand USD | -68.75% |
| 2022 Q2 | 2.24 Million USD | 0.0% |
| 2021 Q2 | -2.23 Million USD | 0.0% |
| 2021 FY | 3.3 Million USD | 40.14% |
| 2020 FY | 2.35 Million USD | -80.46% |
| 2019 Q4 | 6.09 Million USD | 0.0% |
| 2019 FY | 12.06 Million USD | -22.28% |
| 2019 Q2 | 6.05 Million USD | 0.0% |
| 2018 Q4 | 7.75 Million USD | 0.0% |
| 2018 FY | 15.52 Million USD | 25.92% |
| 2018 Q2 | 7.93 Million USD | 0.0% |
| 2017 Q4 | 6.93 Million USD | 0.0% |
| 2017 FY | 12.32 Million USD | 399.05% |
| 2017 Q2 | 5.11 Million USD | 0.0% |
| 2016 Q2 | 3.4 Million USD | 0.0% |
| 2016 Q4 | 3.29 Million USD | 0.0% |
| 2016 FY | 2.47 Million USD | 39.93% |
| 2015 FY | 1.76 Million USD | 3283.27% |
| 2014 FY | 52.17 Thousand USD | -38.06% |
| 2013 FY | 84.23 Thousand USD | -88.07% |
| 2012 FY | 705.91 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 98.02% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 65.067% |
| SQZ Biotechnologies Company | 85.61 Million USD | 97.993% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 94.187% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 95.389% |
| Mesoblast Limited | 5.9 Million USD | 70.892% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -14.386% |
| Genus plc | 147.7 Million USD | 98.837% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 80.431% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -28.059% |
| Marizyme, Inc. | 19.23 Million USD | 91.071% |
| ContraFect Corporation | 56.88 Million USD | 96.98% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 79.398% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | 61.032% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -16.177% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | 41.09% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | 38.432% |
| MultiCell Technologies, Inc. | 567.42 USD | -302667.791% |
| Accustem Sciences Inc. | 3.74 Million USD | 54.144% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 98.001% |
| EV Biologics, Inc. | 531.96 Thousand USD | -222.949% |
| Q BioMed Inc. | 3.43 Million USD | 50.01% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 93.049% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -340.995% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | 34.617% |
| Biomind Labs Inc. | 994.18 Thousand USD | -72.802% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | 99.238% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 74.427% |
| Skye Bioscience, Inc. | 13.54 Million USD | 87.319% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | 16.144% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 6971.86% |
| Arch Therapeutics, Inc. | 5.04 Million USD | 65.927% |
| IMV Inc. | 37.7 Million USD | 95.444% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 89.27% |
| Curative Biotechnology, Inc. | 1.83 Million USD | 6.383% |
| GB Sciences, Inc. | 1.42 Million USD | -20.94% |
| Alpha Cognition Inc. | 9.7 Million USD | 82.299% |
| HST Global, Inc. | 140.9 Thousand USD | -1119.219% |
| CSL Limited | 3.44 Billion USD | 99.95% |
| Halberd Corporation | 74.84 Thousand USD | -2195.456% |
| Enzolytics Inc. | 2.17 Million USD | 21.176% |
| Resverlogix Corp. | 12.71 Million USD | 86.485% |
| Affymax, Inc. | 39.38 Million USD | 95.638% |
| SYBLEU INC | 160.87 Thousand USD | -967.881% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | 52.942% |
| argenx SE | 1.53 Billion USD | 99.888% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 97.009% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -64.556% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -8.776% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | 49.546% |
| AVAX Technologies, Inc. | 7.31 Million USD | 76.499% |
| Zenith Capital Corp. | 8.94 Million USD | 80.79% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.792% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -9761.46% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | 30.031% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -901.676% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 98.27% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | 2.37% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 1.97 Million USD | 12.884% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | 7.853% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 84.191% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | 10.565% |
| BioStem Technologies, Inc. | 22.97 Million USD | 92.522% |
| ONE Bio Corp. | 6.44 Million USD | 73.34% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -846.615% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -28.645% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -52.72% |
| Agentix Corp. | 1.37 Million USD | -25.238% |
| LadRx Corporation | 3.81 Million USD | 54.93% |
| Cell Source, Inc. | 4.32 Million USD | 60.281% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -313.49% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -86.026% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -86.026% |
| NovAccess Global Inc. | 2.46 Million USD | 30.355% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | 28.565% |
| Itoco Inc. | 919.14 Thousand USD | -86.909% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | 59.467% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -53.527% |
| Kadimastem Ltd | 2.41 Million USD | 28.718% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -556.398% |
| CytoDyn Inc. | 18.05 Million USD | 90.486% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -6725.718% |
| Mobile Lads Corp. | 554.54 Thousand USD | -209.797% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -680.616% |
| Qrons Inc. | 643.67 Thousand USD | -166.899% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -21.001% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | 22.957% |
| Rebus Holdings, Inc. | 664 Thousand USD | -158.73% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | 5.415% |
| International Stem Cell Corporation | 5.27 Million USD | 67.407% |
| Bioxytran, Inc. | 3.82 Million USD | 55.029% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -3163.487% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -8344.993% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 95.263% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -6.178% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -133.471% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | 44.778% |
| Neutra Corp. | 243.82 Thousand USD | -604.601% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 90.159% |
| PureTech Health plc | 144.59 Million USD | 98.812% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 91.616% |
| IXICO plc | 4.7 Million USD | 63.502% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 80.471% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 98.541% |
| CSL Limited | 3.89 Billion USD | 99.956% |
| Cellectis S.A. | 97.32 Million USD | 98.235% |